UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Algorithmic Game Theory: 10th International Symposium, SAGT 2017, L'Aquila, Italy, September 12-14, 2017, Proceedings

1st Edition 2017, 2017

Volltextzugriff (PDF)

Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor

Proceedings of the National Academy of Sciences - PNAS, 2016-10, Vol.113 (41), p.E6145-E6152

2016

Volltextzugriff (PDF)

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

The New England journal of medicine, 2012-03, Vol.366 (11), p.1000-1009

2012

Volltextzugriff (PDF)

A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis

Journal of neurology, 2014-04, Vol.261 (4), p.773-783

2014

Volltextzugriff (PDF)

Schwarz type model comparison for LAQ models

Bernoulli : official journal of the Bernoulli Society for Mathematical Statistics and Probability, 2018-08, Vol.24 (3)

2018

Volltextzugriff (PDF)

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

Lancet neurology, 2024-03, Vol.23 (3), p.243-255

2024

Volltextzugriff (PDF)

Laquinimod zur Immunmodulation

InFo Neurologie + Psychiatrie, 2024-05, Vol.26 (5), p.24-25

Saft, Carsten

2024

Volltextzugriff (PDF)

A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis

Neurology, 2020-08, Vol.95 (8)

2020

Volltextzugriff (PDF)

Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination

Acta neuropathologica, 2012-09, Vol.124 (3), p.411-424

2012

Volltextzugriff (PDF)

CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis

Multiple sclerosis, 2022-04, Vol.28 (4), p.608-619

2022

Volltextzugriff (PDF)

Laquinimod exerts anti-inflammatory and antiapoptotic effects in retinal ischemia/reperfusion injury

International immunopharmacology, 2020-11, Vol.88, p.106989-106989, Article 106989

2020

Volltextzugriff (PDF)

Prevalence and factors associated with anxiety and depression amongst hospitalised COVID-19 patients in Laquintinie Hospital Douala, Cameroon

PloS one, 2021-12, Vol.16 (12), p.e0260819-e0260819

2021

Volltextzugriff (PDF)

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

Journal of neurology, neurosurgery and psychiatry, 2014-08, Vol.85 (8), p.851-858

2014

Volltextzugriff (PDF)

Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis

Brain (London, England : 1878), 2013-04, Vol.136 (Pt 4), p.1048-1066

2013

Volltextzugriff (PDF)

Laquinimod, Huntington's disease, and disease modification

Lancet neurology, 2024-03, Vol.23 (3), p.220-221

Mestre, Tiago A

2024

Volltextzugriff (PDF)

Laquinimod attenuates oxidative stress-induced mitochondrial injury and alleviates intervertebral disc degeneration by inhibiting the NF-κB signaling pathway

International immunopharmacology, 2024-04, Vol.131, p.111804-111804, Article 111804

2024

Volltextzugriff (PDF)

The Laqiong Sb-Au deposit: Implications for polymetallic mineral systems in the Tethys-Himalayan zone of southern Tibet, China

Gondwana research, 2019-08, Vol.72, p.83-96

2019

Volltextzugriff (PDF)

A phase II study of laquinimod in Crohn's disease

Gut, 2015-08, Vol.64 (8), p.1227-1235

2015

Volltextzugriff (PDF)

Modulation of Autoimmune Demyelination by Laquinimod via Induction of Brain-Derived Neurotrophic Factor

The American journal of pathology, 2012, Vol.180 (1), p.267-274

2012

Volltextzugriff (PDF)

Laquinimod Treatment Improves Myelination Deficits at the Transcriptional and Ultrastructural Levels in the YAC128 Mouse Model of Huntington Disease

Molecular neurobiology, 2019-06, Vol.56 (6), p.4464-4478

2019

Volltextzugriff (PDF)

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

The Lancet (British edition), 2008-06, Vol.371 (9630), p.2085-2092

2008

Volltextzugriff (PDF)

Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model

Journal of neuroinflammation, 2018-06, Vol.15 (1), p.183-183, Article 183

2018

Volltextzugriff (PDF)

I20 The combined therapy with laquinimod and an essential fatty acid-rich diet has a neuroprotective effect in an acute mice model of Huntington disease

Journal of neurology, neurosurgery and psychiatry, 2022-09, Vol.93 (Suppl 1), p.A91-A92

2022

Volltextzugriff (PDF)

Inhibition of Notch Signaling Enhances Antitumor Activity of Histone Deacetylase Inhibitor LAQ824

International journal of molecular sciences, 2023-09, Vol.24 (17), p.13660

2023

Volltextzugriff (PDF)

Factors associated with sensitisation to selected aero‐allergens in children and adolescents with asthma followed up at Laquintinie Hospital Douala, Cameroon

Pediatric pulmonology, 2024-05, Vol.59 (5), p.1207-1216

2024

Volltextzugriff (PDF)

1 – 25 von 346.957

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194.605)
Mit Volltextzugriff
(255.937)

Publikationsform

Artikel
(238.953)
Dissertationen
(47.065)
Reviews
(23.725)
Buchkapitel
(20.445)
magazinearticle
(6.268)
Zeitungsartikel
(4.143)
Bücher
(2.184)
Tagungsberichte
(1.654)
Newsletter-Artikel
(1.489)
Referenzeintrag
(410)
Texte
(266)
Berichte
(189)
Webseiten
(79)
Datensätze
(53)
government_documents
(28)
market_researchs
(4)
audios
(2)

12 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(195.415)
Französisch
(150.612)
Spanisch
(8.150)
Deutsch
(8.113)
Portugiesisch
(4.648)
Italienisch
(1.514)
Japanisch
(596)
Latein
(420)
Niederländisch
(411)
Rumänisch
(401)
Türkisch
(267)
Katalanisch
(208)
Arabisch
(193)
Chinesisch
(163)
Russisch
(133)
Polnisch
(113)
Ungarisch
(72)
Tschechisch
(62)
Norwegisch
(60)

14 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(57.095)
Life Sciences & Biomedicine
(36.014)
Humans
(19.609)
Physical Sciences
(16.478)
Social Sciences
(13.120)
Technology
(12.953)
Chemistry
(9.326)
Humanities And Social Sciences
(9.278)
Female
(9.042)
Male
(8.841)
Animals
(8.689)
Arts & Humanities
(8.173)
History
(7.987)
Biological And Medical Sciences
(7.454)
Physics
(7.026)
Literature
(6.872)
Materials Science
(6.793)
Engineering
(5.431)
Studies
(5.343)
Adult
(4.871)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(98.197)
Ingenta
(62.917)
JSTOR
(58.558)
ProQuest Dissertations & Theses A&I
(47.050)
IngentaConnect Journals
(31.637)
MEDLINE
(26.320)
Journals@Ovid Ovid Full Text
(22.396)
Publisher or Other Site
(21.601)
Access via ScienceDirect (Elsevier)
(20.049)
Access via Business Source (EBSCOhost)
(16.201)
Wiley-Blackwell Journals
(15.545)
Ebook Central Perpetual and DDA
(14.092)
eBooks on EBSCOhost
(13.502)
Springer Journals
(12.148)
Wiley Online Library
(11.550)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(11.382)
Nexis Uni
(11.170)
Sociological Abstracts
(10.023)
Taylor & Francis
(9.541)
Access via Taylor & Francis
(9.510)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Europe
(8.051)
Revue D'histoire Ecclésiastique
(4.368)
Revue De Métaphysique Et De Morale
(3.253)
Revue De Littérature Comparée
(2.637)
Population
(2.342)
Revue Française De Sociologie
(2.192)
Annales Historiques De La Révolution Française
(2.180)
Les Études Philosophiques
(1.997)
Année Sociologique
(1.882)
Arabica
(1.756)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Algorithmic Game Theory: 10th International Symposium, SAGT 2017, L'Aquila, Italy, September 12-14, 2017, Proceedings

Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis

Schwarz type model comparison for LAQ models

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

Laquinimod zur Immunmodulation

A randomized, placebo-controlled, phase 2 trial of laquinimod in primary progressive multiple sclerosis

Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination

CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis

Laquinimod exerts anti-inflammatory and antiapoptotic effects in retinal ischemia/reperfusion injury

Prevalence and factors associated with anxiety and depression amongst hospitalised COVID-19 patients in Laquintinie Hospital Douala, Cameroon

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis

Laquinimod, Huntington's disease, and disease modification

Laquinimod attenuates oxidative stress-induced mitochondrial injury and alleviates intervertebral disc degeneration by inhibiting the NF-κB signaling pathway

The Laqiong Sb-Au deposit: Implications for polymetallic mineral systems in the Tethys-Himalayan zone of southern Tibet, China

A phase II study of laquinimod in Crohn's disease

Modulation of Autoimmune Demyelination by Laquinimod via Induction of Brain-Derived Neurotrophic Factor

Laquinimod Treatment Improves Myelination Deficits at the Transcriptional and Ultrastructural Levels in the YAC128 Mouse Model of Huntington Disease

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model

I20 The combined therapy with laquinimod and an essential fatty acid-rich diet has a neuroprotective effect in an acute mice model of Huntington disease

Inhibition of Notch Signaling Enhances Antitumor Activity of Histone Deacetylase Inhibitor LAQ824

Factors associated with sensitisation to selected aero‐allergens in children and adolescents with asthma followed up at Laquintinie Hospital Douala, Cameroon

Suchergebnisse filtern